Neither of the two bills to reauthorize and reform a powerful spy tool used by American intelligence agencies will be voted on this week after the Rules Committee pulled the legislation amid intense backlash.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
